Testosterone-Based Health Conditions

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:50 PM on 4/30/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

61 Terms

1
New cards

What phase of the hair cycle is shortened in androgenetic alopecia?

Anagen phase.

2
New cards

What hormone is responsible for follicle miniaturization in AGA?

Dihydrotestosterone (DHT).

3
New cards

What enzyme converts testosterone to DHT?

5-alpha reductase.

4
New cards

What is the MOA of finasteride in AGA?

Inhibits 5-alpha reductase → ↓ DHT → prevents follicle miniaturization.

5
New cards

What is the dose of finasteride for AGA?

1 mg daily.

6
New cards

How long does it take to see full effect of finasteride?

~12 months

7
New cards

What is the MOA of minoxidil?

Vasodilation → ↑ blood flow → stimulates resting follicles.

8
New cards

How should minoxidil be applied?

Topically to the scalp BID.

9
New cards

How long before hair growth is seen with minoxidil?

4-8 months (max at 12-18 months).

10
New cards

What happens if minoxidil is discontinued?

Regrown hair is lost.

11
New cards

Common side effect of topical minoxidil?

Scalp irritation/dermatitis

12
New cards

Is combination therapy with minoxidil and finasteride more effective?

Yes

13
New cards

What two criteria must be met before starting testosterone therapy?

Low testosterone (confirmed) AND symptoms.

14
New cards

When should testosterone levels be measured?

Early morning (7-10 am)

15
New cards

Normal total testosterone range?

300-1000 ng/dL.

16
New cards

Name 3 specific symptoms of low testosterone.

Loss of body hair, gynecomastia, low sperm count.

17
New cards

Name 3 nonspecific symptoms of low testosterone.

↓ muscle mass, depressed mood, ↑ body fat.

18
New cards

What is a major hematologic risk of testosterone therapy?

Polycythemia

19
New cards

What cardiovascular effect can testosterone cause?

↑ BP (~6 mmHg).

20
New cards

How does testosterone affect fertility?

↓ spermatogenesis.

21
New cards

Absolute contraindication to testosterone therapy?

Prostate cancer.

22
New cards

Hematocrit level that contraindicates therapy?

> 52%

23
New cards

What is the risk of transdermal testosterone to others?

Secondary exposure (boxed warning).

24
New cards

How often should testosterone levels be monitored after stabilization?

Annually

25
New cards

When should gel testosterone levels be checked?

Prior to morning dose (trough).

26
New cards

When should injectable testosterone levels be checked?

Midpoint or trough between doses.

27
New cards

What symptom score is used to assess BPH severity?

IPSS (International Prostate Symptom Score).

28
New cards

Goal IPSS reduction with therapy?

≥3 point decrease.

29
New cards

First-line medication class for BPH?

Alpha blockers

30
New cards

MOA of alpha blockers?

Relax smooth muscle in bladder neck → improve urine flow.

31
New cards

Onset of action of alpha blockers?

4-6 weeks.

32
New cards

Common ADE of alpha blockers?

Orthostatic hypotension.

33
New cards

What is first-dose phenomenon?

Severe orthostatic hypotension after initial dose.

34
New cards

Which alpha blockers commonly cause ejaculatory dysfunction?

Tamsulosin and silodosin.

35
New cards

What serious ophthalmologic condition is associated with alpha blockers?

Intraoperative floppy iris syndrome.

36
New cards

MOA of 5-alpha reductase inhibitors in BPH?

Shrink prostate by ↓ DHT.

37
New cards

When are 5ARIs indicated?

Enlarged prostate (>30 cc or PSA >1.5).

38
New cards

Onset of action of 5ARIs?

3-6 months.

39
New cards

Do 5ARIs reduce prostate cancer risk?

↓ overall risk by 25% but ↑ high-grade cancer detection.

40
New cards

Which PDE-5 inhibitor is approved for BPH?

Tadalafil 5 mg daily

41
New cards

Recommended combination therapy for enlarged prostate?

Alpha blocker + 5ARI.

42
New cards

Is tadalafil + alpha blocker recommended?

No (↑ adverse effects).

43
New cards

Is saw palmetto recommended for BPH?

No

44
New cards

First-line pharmacologic therapy for ED?

PDE-5 inhibitors.

45
New cards

MOA of PDE-5 inhibitors?

Block breakdown of cGMP → prolonged vasodilation.

46
New cards

Do PDE-5 inhibitors require sexual stimulation?

Yes

47
New cards

Absolute contraindication to PDE-5 inhibitors?

Concomitant nitrate use.

48
New cards

Serious adverse effect requiring ER visit?

Priapism (>4 hours).

49
New cards

Rare vision complication of PDE-5 inhibitors?

NAION

50
New cards

Which PDE-5 inhibitor has the longest half-life?

Tadalafil (36 hours).

51
New cards

Which PDE-5 inhibitor has the fastest onset?

Avanafil

52
New cards

Which PDE-5 inhibitors are affected by high-fat meals?

Sildenafil and vardenafil.

53
New cards

How many doses are needed for an adequate PDE-5 trial?

5-8 doses

54
New cards

Second-line therapy after PDE-5 failure?

Alprostadil

55
New cards

MOA of alprostadil?

Prostaglandin E1 → smooth muscle relaxation → vasodilation.

56
New cards

First dose of alprostadil should be given where?

Under provider supervision.

57
New cards

What dose of finasteride is used for BPH?

5 mg

58
New cards

What dose of finasteride is used for alopecia?

1 mg

59
New cards

What lab must be monitored closely during testosterone therapy to prevent VTE risk?

Hematocrit

60
New cards

Which BPH drugs also treat hypertension?

Doxazosin and terazosin.

61
New cards

Which medications for ED also treat BPH?

Tadalafil